ulipristal acetate has been researched along with vilaprisan in 3 studies
Studies (ulipristal acetate) | Trials (ulipristal acetate) | Recent Studies (post-2010) (ulipristal acetate) | Studies (vilaprisan) | Trials (vilaprisan) | Recent Studies (post-2010) (vilaprisan) |
---|---|---|---|---|---|
376 | 41 | 347 | 19 | 10 | 19 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bumbuliene, Ž; Costa, AR; Gemzell-Danielsson, K; Heikinheimo, O; Heweker, A; Hudeček, R; Jacquemyn, Y; Melis, GB; Parashar, P; Rechberger, T; Sánchez, AC; Seitz, C; van Aken, B; Zatik, J | 1 |
Belland, L; Leyland, N; Murji, A; Singh, SS; von Riedemann, S | 1 |
Ajossa, S; Corda, V; Giancane, E; Mais, V; Marotto, MF; Melis, GB; Neri, M; Paoletti, AM; Pilloni, M; Piras, B; Saba, A | 1 |
2 review(s) available for ulipristal acetate and vilaprisan
Article | Year |
---|---|
The past, present, and future of selective progesterone receptor modulators in the management of uterine fibroids.
Topics: Contraceptive Agents, Female; Disease Management; Estrenes; Female; Forecasting; Humans; Leiomyoma; Mifepristone; Norpregnadienes; Oximes; Population Growth; Receptors, Progesterone; Steroids; Uterine Neoplasms | 2018 |
Vilaprisan for treating uterine fibroids.
Topics: Animals; Female; Humans; Leiomyoma; Norpregnadienes; Receptors, Progesterone; Steroids; Time Factors; Uterine Hemorrhage; Uterine Neoplasms | 2018 |
1 trial(s) available for ulipristal acetate and vilaprisan
Article | Year |
---|---|
Rationale and design of ASTEROID 2, a randomized, placebo- and active comparator-controlled study to assess the efficacy and safety of vilaprisan in patients with uterine fibroids.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Double-Blind Method; Drug Administration Schedule; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Quality of Life; Research Design; Steroids; Young Adult | 2017 |